A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis

@article{Abolmaali2012ARO,
  title={A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis},
  author={S. Abolmaali and A. Tamaddon and R. Dinarvand},
  journal={Cancer Chemotherapy and Pharmacology},
  year={2012},
  volume={71},
  pages={1115-1130}
}
  • S. Abolmaali, A. Tamaddon, R. Dinarvand
  • Published 2012
  • Medicine
  • Cancer Chemotherapy and Pharmacology
  • PurposeMethotrexate (MTX) is one of the most widely studied and effective therapeutics agents available to treat many solid tumors, hematologic malignancies, and autoimmune diseases such as rheumatoid arthritis; however, the poor pharmacokinetic and narrow safety margin of the drug limits the therapeutic outcomes of conventional drug delivery systems. For an improved delivery of MTX, several pathophysiological features such as angiogenesis, enhanced permeability and retention effects, acidosis… CONTINUE READING
    Targeted Co-Delivery of siRNA and Methotrexate for Tumor Therapy via Mixed Micelles
    2

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 129 REFERENCES
    Albumin-Based Drug Delivery as Novel Therapeutic Approach for Rheumatoid Arthritis1
    153
    Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model.
    250
    Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-l-lysine dendrimers.
    107
    Investigation of nano lipid vesicles of methotrexate for anti-rheumatoid activity
    31